Innovation Type:
Diagnostics
Cancer Type:
Other
Funding Stage:
Exit
Fund:
Compass Rose
Development of a colon cancer risk prediction diagnostic tool

Related news

There are currently no news items related to this portfolio company.

    CONNECT WITH FACIT

    Learn more about how we are driving made-in-Ontario oncology innovations reach the market.
    Please note that only Ontario-based innovations related to oncology and cancer care are eligible for FACIT's commercialization support.